Long-term Follow-up of Cognitive and Functional Evolutions of Persons With Isolated Cognitive Complaints or Mild Cognitive Deficits (Memento-Plus)

University Hospital of Bordeaux

Status: Completed

Conditions: Alzheimer Disease

Study type: Observational

Funder types: Other

Identifiers

NCT04111211

CHUBX 2019/16

Details and patient eligibility

About

Dementia is a clinical syndrome that is the result of distinct underlying pathologies including Alzheimer's disease (AD). Despite more than two decades of research on prevention and treatment of dementia and aging-related cognitive decline, highly effective preventive and therapeutic strategies remain elusive.

Many features of dementia render it especially challenging. Indeed development of disease occurs insidiously over the course of years or decade. In addition, the causes of dementia and determinants of its severity are likely multi-factorial.

To overcome these challenges and better understand the causes and course of AD and related disorders, long term follow-up studies of persons at high risk of dementia are required including multidimensional and harmonized assessment of risk factors, phenotypes (cognition, neuropsychiatric symptoms, physical health, self rated health) and endophenotypes (blood markers, genetic markers, neuroimaging markers).

This project proposes an extension of the follow-up of Memento participants over 5 to 10 years with of focus on cognitive outcomes and comorbidities.

Enrollment: 1,028 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participants aged over 18 year-old
• Being included in Memento cohort
• Affiliated person or beneficiary of a social security scheme.
• Participants capable of expressing non objection
• Non objection expressed by the tutor for participants under tutorship
• Non objection expressed by the participant assisted by their guardian for participants under guardianship
• Non objection expressed by the trusted person (in accordance with art. L1111-6 of Code de la Santé Publique) for participants without the capacity to express non-objection and who are not under legal protection measure

Exclusion criteria

• Expressing opposition to participate in Memento-Plus

Trial design

1,028 participants in 1 patient group

Individuals at high risk of developing Alzheimer's dementia